Data / Form D filings / COLLEGIUM PHARMACEUTICAL, INC
COLLEGIUM PHARMACEUTICAL, INC: Form D filings
COLLEGIUM PHARMACEUTICAL, INC, a pharmaceuticals company in Stoughton, MA, filed 5 Form D notices with the SEC between 2010 and 2018. The latest, on November 13, 2018, reports $20 million sold of a $20 million offering to 1 investor.
Find out what COLLEGIUM PHARMACEUTICAL, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 TECHNOLOGY CENTER DRIVE, Stoughton, MA, 02072
- Phone
- (781) 713-3699
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Virginia
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1267565
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 13, 2018 | New notice | $20,000,006 | $20,000,006 | $0 | 1 | Nov 8, 2018 | sec.gov |
| Mar 13, 2015 | New notice | $50,000,000 | $50,000,000 | $0 | 18 | Mar 6, 2015 | sec.gov |
| Oct 2, 2013 | New notice | $12,000,000 | $4,000,002 | $7,999,998 | 13 | Aug 27, 2013 | sec.gov |
| Feb 24, 2012 | New notice | $22,461,190 | $22,461,190 | $0 | 12 | Feb 10, 2012 | sec.gov |
| Mar 8, 2010 | New notice | $2,500,000 | $1,000,000 | $1,500,000 | 7 | Mar 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Heffernan | Director | |
| David Hirsch | Director | |
| Garen Bohlin | Director | |
| Shirley B. Kuhlmann | Executive Officer | |
| Theodore A Schroeder | Director | |
| John A Fallon | Director | |
| Alison B. Fleming | Executive Officer | |
| Gwen A Melincoff | Director | |
| Gino Santini | Director | |
| Scott B. Dreyer | Executive Officer | |
| Joseph Ciaffoni | Executive Officer, Director | |
| John Freund | Director | |
| Paul Brannelly | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Nov 12, 2018 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what COLLEGIUM PHARMACEUTICAL, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.